搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Cure Today
6 小时
Calquence Plus Venclexta Combo May Improve Survival in Frontline CLL
Calquence plus Venclexta, with or without Gazyva, improved progression-free survival over the standard-of-care ...
19 小时
I've had earache for months, and fear that losing my husband is to blame. DR ELLIE reveals ...
My husband died in August after a long illness. I've suffered since with an earache, swollen face, flu-like symptoms and ...
Le Lézard
13 小时
Kite Presents New Data Underscoring Curative Potential of Yescarta® in Relapsed/Refractory ...
Kite, a Gilead Company , today announced findings from three new analyses for Yescarta® (axicabtagene ciloleucel) that demonstrate improved outcomes for people living with relapsed or refractory (R/R) ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Record 15-yr, $765M deal
Calls for Ukraine ceasefire
Tops box office again
Delivers remarks on Syria
Accused in civil lawsuit
SK pres avoids impeachment
CFP: 12-team bracket
Wins Grand Prix Final
Ruby slippers sell for $28M
Chipotle raising US prices
‘Dynasty' actor dies at 77
To run for top Democrat
Murder suspect recaptured
$965 million verdict upheld
Camerota to exit CNN
Wins Ghana election
Assad, family in Moscow?
Fined for obscene gesture
Galaxy win 6th MLS Cup
Threat prompts evacuation
Bomb threat targets Trahan
Returning to coach UCF
Israel shells Gaza hospital?
Producer Maslansky dies
More drone sightings in NJ
PA grandmother found dead
NFL ends Watson probe
WHO probes Congo disease
Sailor laid to rest
Counselor to the president
CFPB sues Comerica Bank
US airstrikes hit ISIS camps
反馈